madman
Super Moderator
In this clip from our 2022 mid-year update conference, Mark Moyad, MD, MPH asks Matthew Cooperberg, MD, MPH, about the use of Avodart (dutasteride) and Proscar (finasteride) in men on active surveillance. Dr. Cooperberg explains that the early belief that these medications increased the incidence of more aggressive prostate cancers was mistaken and that they actually only increased the detection rate of aggressive cancers by making PSA a more reliable indicator. Moreover, new data suggests that they decrease the rate of cancer progression for men on active surveillance; however, there are possible side effects and men should speak with their doctors as to whether these are good medications to consider while on active surveillance.